Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
biote ( (BTMD) ) just unveiled an announcement.
On January 30, 2025, Biote Corp. announced the retirement of CEO Terry Weber, effective February 1, 2025, who will transition to a strategic advisor role. Bret Christensen, an experienced executive in women’s health and the broader healthcare sector, will succeed Weber as CEO and Director, bringing his extensive expertise to drive Biote’s growth and value creation for stakeholders.
More about biote
Biote Corp. is a leading solutions provider in the preventive health care industry, specializing in personalized hormone optimization and therapeutic wellness. The company focuses on transforming healthy aging through innovative solutions offered by Biote-certified medical providers, targeting an underserved global market to provide affordable symptom relief and drive clinic success.
YTD Price Performance: -5.80%
Average Trading Volume: 140,726
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $311.9M
See more data about BTMD stock on TipRanks’ Stock Analysis page.